Analyst consensus rating
Vor Biopharma Analyst Rating: Strong Buy
VOR is rated Strong Buy by 8 analysts with a $39.00 target. As of 2026-08-26.
Direct answer
Vor Biopharma's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $39.00.
Forecast evidence checked August 26, 2026.
Get free Vor Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $24.01
- Average price target
- $39.00
- High price target
- $50.00
- Low price target
- $27.00
- Low target gap
- +12.5%
- Target upside
- +62.4%
- High target gap
- +108.2%
- Target range width
- 95.8%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Vor Biopharma?
Vor Biopharma has a verified Strong Buy consensus. The same dataset has an average price target of $39.00.
How far are Vor Biopharma's low and high targets from the recorded price?
The low target implies +12.5%, while the high target implies +108.2%.
How many analysts are included in Vor Biopharma's consensus?
The verified consensus includes 8 analysts.
How is Vor Biopharma's target upside or downside calculated?
The average target of $39.00 is divided by the recorded price of $24.01, then one is subtracted to produce +62.4%. This does not guarantee a future return.
When was Vor Biopharma's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.